The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 23, 2018

Filed:

Dec. 29, 2014
Applicant:

Verily Life Sciences Llc, Mountain View, CA (US);

Inventors:

Kimberly Kam, Mountain View, CA (US);

Jerrod Joseph Schwartz, San Francisco, CA (US);

Gary Tong, Berkeley, CA (US);

Assignee:

VERILY LIFE SCIENCES LLC, South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/1455 (2006.01); A61B 5/145 (2006.01); A61B 10/00 (2006.01); A61B 5/00 (2006.01); A61M 5/158 (2006.01); A61M 5/172 (2006.01);
U.S. Cl.
CPC ...
A61B 5/14514 (2013.01); A61B 5/1455 (2013.01); A61B 5/14539 (2013.01); A61B 5/4839 (2013.01); A61B 5/6833 (2013.01); A61B 10/0045 (2013.01); A61M 5/158 (2013.01); A61M 5/1723 (2013.01); A61B 2010/008 (2013.01); A61M 2005/1726 (2013.01);
Abstract

Devices are provided that include a plurality of microneedles that penetrate skin and that receive interstitial fluid from the skin tissue. The microneedles are further configured to direct the received interstitial fluid to nanosensors configured to change an optical property based on interaction with an analyte in the received interstitial fluid, allowing optical detection of the analyte. Direction of the received interstitial fluid to the nanosensors can be facilitated by a pump configured to control the flow rate of the interstitial fluid through the microneedles. Such devices could be configured to detect the analyte independently or in combination with a reader device configured to be periodically mounted to the devices and to detect the analyte. Further, such devices can include delivery systems configured to transdermally deliver a drug or other substance into or through the skin in response to a detected concentration, presence, or other property of the analyte.


Find Patent Forward Citations

Loading…